Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802020 · ClinicalTrials.gov registry record · NA
WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02802020 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 67 participants.
The verdict
NCT02802020, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
To prospectively document the performance of a FCSEMS for treatment of pancreatic duct strictures in patients with painful chronic pancreatitis.
Interventions
- DEVICE Pancreatic fully-covered self-expanding metal stent (FCSEMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2017-01-25 |
| Est. Completion | 2021-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802020
The ClinicalTrials.gov registry entry for NCT02802020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pancreatic fully-covered self-expanding metal stent (FCSEMS) is the first listed.
NCT02802020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02802020 about?
NCT02802020 is a clinical study titled "WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures". To prospectively document the performance of a FCSEMS for treatment of pancreatic duct strictures in patients with painful chronic pancreatitis.
What is the current status of trial NCT02802020?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2017-01-25. Estimated completion is 2021-11-24.
What interventions are being tested in trial NCT02802020?
The interventions under investigation include: Pancreatic fully-covered self-expanding metal stent (FCSEMS) (DEVICE).
Who is sponsoring clinical trial NCT02802020?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.